The present invention relates to enzyme inhibitors. More specifically, the present invention relates to ligand-directed covalent modification of proteins; method of designing same; pharmaceutical formulation of same; and method of use.
Legal claims defining the scope of protection, as filed with the USPTO.
2. The conjugate of claim 1, wherein the conjugate of Formula XIII is a conjugate of Formula XIII′:,
5. The conjugate of claim 2, wherein Y1 is a moiety of Formula XV-a:,
6. The conjugate of claim 2, wherein Y1 is a moiety of Formula XV-b:,
7. The conjugate of claim 2, wherein Y1 is a moiety of Formula XV-d:,
Cooperative Patent Classification codes for this invention. Click any code to explore related patents in that topic.
February 2, 2017
January 3, 2023
Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.